Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Pharmacology Studies
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Interneuron-based mechanisms of temporal lobe epilepsy
PathMiner: Web Telemicroscopy &Intelligent Databases
Mechanisms of Recombinational DNA Repair
Mechanisms of Nuclear Protein Import
Ahec Spec Initiative-Hlth Promotion/Disease Prev. (OSU)
Recently added grants:
Common and rare sequence variants in breast cancer risk
Control of quiescence and outgrowth in latent breast preneoplastic cells
MerTK and the Innate Immune Response to Melanoma
Guanylin GUCY2C axis in Colorectal Cancer Initiation
Macrophage-based ovarian cancer immunotherapy
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52204-11-0-1
Application #
7584876
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacology Studies of Antitumor &Other Therapeutic Agents
/ University of Texas MD Anderson Cancer Center
$308,593
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Newman, Robert /
$414,826
NIH 2007
N01 CA
Preclinical Pharmacology Studies
/
Comments
Be the first to comment on this grant